medical cannabis

A new world beckons for the listed medical cannabis stocks, but liberalisation is not what it seems

Tim Boreham
Tim Boreham
Independent Investment Research

The New Criterion: all the dope on Emerald Clinics’ limp debut

Tim Boreham
Tim Boreham
Independent Investment Research

The New Criterion: the emerging winners in ‘cannabis corner’

Tim Boreham
Tim Boreham
Independent Investment Research

The New Criterion: pot plays mull over their strategies as sector goes off the boil

Tim Boreham
Tim Boreham
Independent Investment Research

Hot thematics and how to approach them

Livewire Exclusive
Livewire Exclusive
Livewire Markets

When researching companies, expect the unexpected.

PM Capital
PM Capital
PM Capital

The New Criterion: investors rush veterinary cannabis listing

Tim Boreham
Tim Boreham
Independent Investment Research